High dose radionuclide complexes for bone marrow treatment
US7696331B2 · kind B2 · utility
5Cited by
108References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 19, 2008 |
| Grant date | Apr 13, 2010 |
| Priority date | — |
| Expiry date | Jun 19, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a method of suppressing bone marrow (BM) and treating conditions that arise in or near bone such as cancer, myeloproliferative diseases, autoimmune diseases, infectious diseases, metabolic diseases or genetic diseases, with compositions having as their active ingredient a radionuclide complexed with a chelating agent such as macrocyclic aminophosphonic acid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.